Since the inaugural leadership forum in 2011 and follow-up engagement in 2017, “Rethinking Malaria” fora uphold a longstanding academic tradition of convening multidisciplinary perspectives from diverse stakeholders in a neutral environment. “Rethinking Malaria” forums push beyond conventional thinking to question fundamental assumptions and approaches, with a focus on bold new ideas to achieve real-world progress.
We need a global effort to rethink malaria, that takes into account the perspectives of those at the front line. Progress in reducing the malaria burden in the world has plateaued in the last few years, after fifteen years of progressive reductions which resulted in an overall 50% reduction in burden and in deaths. The ongoing COVID-19 pandemic has further threatened the bold ambition of the World Health Organization (WHO) Global Technical Strategy for Malaria 2016–2030.
COVID-19 has created new challenges for both human and financial resources and the delivery of essential malaria services. In short, it is time to take stock—what lessons have we learned from our earlier success that apply to our current context and where have our approaches fallen short? What are the most important next steps in addressing global malaria?
In 2021, Harvard University’s Defeating Malaria: From the Genes to the Globe Initiative will convene a global engagement focused on “Rethinking Malaria Strategy in the Context of COVID–19” in partnership with the World Health Organization.
This effort incorporates learnings from the growing body of evidence—including the Malaria Eradication Research Agenda (malERA) Refresh, World Malaria Report 2020, WHO Strategic Advisory Group on Malaria Eradication (SAGme), Lancet Commission on Malaria Eradication, etc.—to address the plateau to control and eradicate malaria in Africa.
The recent stalling of global progress on malaria has been further compounded by COVID–19. Learn more about the discussions that have contributed to the framework of this effort
The goal of “Rethinking Malaria Strategy in the Context of COVID–19” is to identify novel ‘game-changing’ approaches to the malaria crisis with the following objectives:
The following workstreams have been organized to achieve the goal and objectives of this effort at “Rethinking Malaria.” Together, these Working Groups will consult with a range of stakeholders with a focus on those working on the front lines and those most affected by the disease to consider malaria challenges and opportunities in the context of COVID–19 in Africa.
Guiding questions across the above-noted topics/themes include: (1) Who is deciding? (e.g., global financing decision-making); (2) How do we more effectively—and more equitably—deliver services universally (everyone, but not everything)? and (3) What is the current and necessary capacity to solve problems at the country-level?
As part of this “Rethinking Malaria” process, the WHO’s Global Malaria Programme will coordinate a regional consultative process, which will also begin with the continent with the highest burden of malaria.
A small research staff supports this effort. An external Advisory Committee composed of experts and thought leaders provides feedback on the global public good deliverables for the “Rethinking Malaria Strategy in the Context of COVID–19.”
This “Rethinking Malaria” engagement is sponsored by the Bill & Melinda Gates Foundation, J.C. Flowers Foundations, Harvard University’s Defeating Malaria: From the Genes to the Globe Initiative, and the Takemi Program in International Health at the Harvard Chan.
Please contact Carmen Mejia, Executive Director, Harvard University’s Defeating Malaria: From the Genes to the Globe Initiative with questions.
